Purpose: To present five patients with VIth nerve palsy and ipsilateral Horner's Syndrome (HS), as a result of cavernous sinus alteration. Study design: Consecutive case series. Material and methods: Five patients presented abducens palsy with horizontal diplopia (3 in primary position and 2 in lateral gaze only) and ipsilateral HS. Apraclonidine 0.5% drops evidenced sympathetic denervation in all patients 40-60 min after instillation. All 5 cases had neuroimages (MRI in 3 cases, Computerized Tomography -CT in one case and Magnetic Resonance Angiography -MRA in one case) demonstrating cavernous sinus lesions; 2 meningiomas, 1 carotid-cavernous aneurism, 1 foreign body (bullet) and 1 squamous cell carcinoma. Conclusion: Lesions on the cavernous sinus need to be considered in cases of abducens nerve palsy and ipsilateral Horner's Syndrome.
Introduction
Disfunction of the sixth (abducens) cranial nerve may result from lesions occurring anywhere along its pathway between the sixth nerve nucleus in the dorsal pons and the lateral rectus muscle within the orbit.
Horner Syndrome can be caused by damage to the sympathetic pathway at any location of its route from the hypothalamus to the eye.
The association of the sixth nerve palsy with ipsilateral Horner's Syndrome has a localizing value in the posterior cavernous sinus, also known as Parkinson's Syndrome. The syndrome has been described mainly in aneurisms in and around the posterior cavernous sinus presenting acutely with variable pain or anesthesia-hypoesthesia in the side of the lesion.
We present five patients with VIth nerve palsy and ipsilateral Horner's Syndrome (HS), an association orienting diagnosis toward the cavernous sinus.
Material and methods
Consecutive case series of five patients with horizontal diplopia secondary to VIth nerve palsy and HS with ipsilateral cavernous sinus lesion has been registered with the institutional review board and followed the tenets of the Declaration of Helsinki. After clinical diagnosis all patients were asked for neuroimaging. The diagnosis of Horner Syndrome was performed by pharmacological test with Apraclonidine 0.5% in order to confirm the sympathetic denervation feature observed (Figs. 1-4).
Results
Five patients are presented, with age range between 25 and 70 years, all patients had abducens palsy with horizontal diplopia in primary position (3 patients) or evident in lateral gaze only (2 patients) and ipsilateral Horner's Syndrome (Table 1 ). Apraclonidine 0.5% drops, evidenced sympathetic denervation in all patients 40-60 min after instillation. Patients had neuroimages (MRI in 3 cases, Computerized Tomography -CT in one case and Magnetic Resonance Angiography -MRA in one case) demonstrating cavernous sinus lesions; 2 meningiomas, 1 carotid-cavernous aneurism, 1 foreign body (bullet) and 1 squamous cell carcinoma.
Discussion
The cavernous sinus is a structure that contains, in its lateral (meningeal) wall the oculomotor (IIIrd nerve), trochlear (IVth nerve) and the first two divisions of the trigeminal nerve. Inside the cavernous sinus, contains the abducens (VIth nerve) and the oculosympathetic nerve plexus around the internal carotid artery.
These anatomical distributions are the cause of either solitary or combined diverse impairments of cranial nerves and eventual postganglionic Horner's Syndrome.
Isolated VIth nerve palsy or Horner Syndrome alone, has no localizing value per se, neuroimaging or pharmacological tests are necessary to determine the injury site.
The association of VIth nerve palsy with ipsilateral HS, described by Parkinson and named after him (PS), 1,2 has a great localizing value, being the cavernous sinus the site of the lesion.
The sympathetic plexus and the VIth nerve attempt can be explained by the close anatomical relationship between these two elements inside the cavernous sinus (Fig. 5) . A single lesion may produce both deficits simultaneously.
The most frequent etiologies reported for PS are; aneurism, invasive tumors, trauma, meningioma and giant cell arteritis. [3] [4] [5] [6] [7] In our small series of five cases we found two meningiomas, one carotid-cavernous aneurism, 1 foreign body (bullet) and a squamous cell carcinoma as responsible for PS. Neuroimaging (MRI, CT and Angiography) confirmed the initial clinical diagnostic showing cavernous sinus lesions in all our patients.
The use of Apraclonidine 0.5% has a great diagnostic value for HS but does not provide information about the level of the sympathetic pathway lesion. In our five cases helped to confirm the presence of sympathetic denervation (ipsilateral to the VI nerve deficit). In conclusion, neuroimaging of the cavernous sinus is recommended in the study of Parkinson's Syndrome, choosing images according to the nature of the suspected causing factor. Apraclonidine 0.5% is a helpful test for the detection of sympathetic denervation.
